Company Directory / Biotechnology

PrivateFor profitBiotechnologyGosselies, Walloon Region, Belgium
OncoDNA is a company specialized in precision medicine for the treatment of cancer.
OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its… Read all
OncoDNA is a genomic and theranostic company specializing in precision medicine for the treatment of cancer and genetic diseases. The company helps clinicians, academic researchers and biopharma companies to outsmart molecular complexity with the mission of delivering the promise of precision medicine. The company not only provides clinical guidance for the treatment and real-time monitoring of late-stage cancer patients but also supports research and drug development in cancer and genetic diseases. Since its early days in 2012, OncoDNA has grown into a corporate group of companies with world-renowned expertise. The Group offers a unique portfolio that combines NGS services, biomarker testing, data interpretation software, and clinical decision support tools. OncoDNA is headquartered in Belgium, and its entities – Biosequence and IntegraGen – are based in Spain, France and the United States. The Group employs over 100 employees across 9 countries, works with an international network of 35 distributors and collaborates with both European-based and US-based subcontracted accredited laboratories.
Size
101-250 people: larger than 85% of companies with a size listed. 50 people list it on LinkedIn.
Age
14 years old.
Reach
Website ranked #7,270,168 in the world for traffic, about 832 visits a month. 14,236 followers on LinkedIn.
BiotechnologyHealth CareHealth DiagnosticsPrecision Medicinebioinformaticstheranosticsmolecular diagnosticsbiomarker testinggenomicsoncologyprecision medicine
Funding, as listed
$27M raised in total
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about OncoDNA, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
OncoDNA may be growing as evidenced by the launch of the OncoDEEP Solid Tumor Biomarker Test in February 2022, which indicates an expansion of their product offerings. The company is also listed among other key players in the cancer profiling market, suggesting a competitive presence in the industry. Furthermore, the mention of OncoDNA in the context of a campaign post COVID-19 implies ongoing marketing efforts and potential market engagement.
Summaries written by the source dataset, not by us, and not checked.
Biotechnology in Belgium.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 36,920 companies in Belgium and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.